Estrogen therapy in older patients with recurrent urinary tract infections: A review

International Journal of Fertility and Women's Medicine

Volumn 49, Issue 2, 2004, Pages 71-74

  Rozenberg, S ^a   Pastijn, A ^a   Gevers, R ^a   Murillo, D ^a  

^a SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Menopause; Topical estrogen; Vaginal administration; Vaginal atrophy

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTRIOL; ESTROGEN; MEDROXYPROGESTERONE ACETATE;

ADULT; AGED; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DYSURIA; ESTROGEN THERAPY; FEMALE; HUMAN; MENOPAUSE; META ANALYSIS; OUTCOMES RESEARCH; POSTMENOPAUSE; PRIORITY JOURNAL; RECURRENT INFECTION; REVIEW; SYSTEMATIC REVIEW; URINARY TRACT INFECTION; VAGINA ATROPHY; VAGINA FLORA; VAGINA RING;

ADMINISTRATION, INTRAVAGINAL; AGED; CLINICAL TRIALS; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; MIDDLE AGED; POSTMENOPAUSE; RECURRENCE; RISK FACTORS; URINARY TRACT INFECTIONS; UROGENITAL SYSTEM; VAGINA; WOMEN'S HEALTH;

EID: 2542450256     PISSN: 1534892X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Molander U, Arvidsson L, Milsom I, et al: A longitudinal cohort study of elderly women with urinary tract infections. Maturitas 34:127-131, 2000.
2. Falconer C, Ekman-Ordeberg G, Ulmsten U, et al: Changes in paraurethral connective tissue at menopause are counteracted by estrogen. Maturitas 24:197-204, 1996.
3. Hextall A: Oestrogens and lower urinary tract function. Maturitas 36:83-92, 2000.
4. Orlander JD, Jick SS, Dean AD, et al: Urinary tract infections and estrogen use in older women. J Am Geriatr Soc 40:817-820, 1992.
5. Foxman B, Somsel P, Tallman P, et al: Urinary tract infection among women aged 40 to 65: Behavioral and sexual risk factors. J Clin Epidemiol 54:710-718, 2001.
6. Parsons CL, Schmidt JD: Control of recurrent lower urinary tract infections in postmenopausal women. J Urol 128:1224-1226, 1982.
7. Brandberg A, Mellstrom D, Samsioe G: Low dose oral oestriol treatment in elderly women with urogenital infections. Acta Obstet Gynecol Scand 140:33-38, 1987.
8. Privette M, Cade R, Peterson J, et al: Prevention of recurrent urinary tract infections in postmenopausal women. Nephron 50:24-27, 1988.
9. Kirkengen AL, Anderson P, Gjersoe E, et al: Oestriol in the prophylactic treatment of recurrent urinary tract infections in postmenopausal women. Scand J Prim Health Care 10:139-142, 1992.
10. Raz R, Stamm WE: A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 329:753-756, 1993.
11. Erikesen B: A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women. Am J Obstet Gynecol 180:1072-1079, 1999.
12. Cardozo LD, Benness C, Abbott D: Low dose oestrogen prophylaxis for recurrent urinary tract infections in elderly women. Br J Obstet Gynaecol 105:403-407, 1998.
13. Brown JS, Vittinghoff E, Kanaya AM, et al and Heart and Estrogen/Progestin Replacement Study Research Group: Urinary tract infections in postmenopausal women: effect of hormone therapy and risk factors. Obstet Gynecol 98:1045-1052, 2001.
14. Kanaya AM, Herrington D, Vittinghoff E, et al: Glycemic effects of postmenopausal hormone therapy: The Heart and Estrogen/progestin Replacement Study: A randomized, double-blind, placebo-controlled trial. Ann Intern Med 138:1-9, 2003.
15. Cardozo L, Lose G, McLish D, et al: A systematic review of estrogens for recurrent urinary tract infections. Int Urogynecol J 10(Suppl 1):S32, 1999.